Ocean Biomedical, Inc. (OCEA)
OTCMKTS · Delayed Price · Currency is USD
0.0066
-0.0005 (-7.04%)
Jul 18, 2025, 3:57 PM EDT

Ocean Biomedical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Selling, General & Admin
4.143.779.517.7128.411.6
Upgrade
Research & Development
0.020.030.718.4133.930.05
Upgrade
Operating Expenses
4.163.810.2116.1262.351.65
Upgrade
Operating Income
-4.16-3.8-10.21-16.12-62.35-1.65
Upgrade
Interest Expense
-1.75-2.05-1.76-1.24--
Upgrade
Earnings From Equity Investments
-1.06-3.3-0.71---
Upgrade
Currency Exchange Gain (Loss)
----0-
Upgrade
Other Non Operating Income (Expenses)
-23.75-0.34-86.70.01--0
Upgrade
EBT Excluding Unusual Items
-30.72-9.48-99.39-17.36-62.34-1.65
Upgrade
Other Unusual Items
---15.08---
Upgrade
Pretax Income
-30.72-9.48-114.47-17.36-62.34-1.65
Upgrade
Net Income
-30.72-9.48-114.47-17.36-62.34-1.65
Upgrade
Net Income to Common
-30.72-9.48-114.47-17.36-62.34-1.65
Upgrade
Shares Outstanding (Basic)
432826231717
Upgrade
Shares Outstanding (Diluted)
432826231717
Upgrade
Shares Change (YoY)
61.28%4.60%12.57%33.56%0.19%-
Upgrade
EPS (Basic)
-0.71-0.34-4.35-0.74-3.57-0.09
Upgrade
EPS (Diluted)
-0.71-0.34-4.35-0.74-3.57-0.09
Upgrade
EBIT
-4.16-3.8-10.21-16.12-62.35-1.65
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.